Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

A Panel of Circulating MicroRNAs Detects Uveal Melanoma With High Precision.

Stark MS, Gray ES, Isaacs T, Chen FK, Millward M, McEvoy A, Zaenker P, Ziman M, Soyer HP, Glasson WJ, Warrier SK, Stark AL, Rolfe OJ, Palmer JM, Hayward NK.

Transl Vis Sci Technol. 2019 Nov 14;8(6):12. doi: 10.1167/tvst.8.6.12. eCollection 2019 Nov.

2.

Cannabis abuse and dependence in kidney transplant candidates.

Stark AL, Hickson LJ, Larrabee BR, Thusius NJ, Karpyak VM, Hall-Flavin DK, Schneekloth TD.

J Psychosom Res. 2019 Jun;121:68-73. doi: 10.1016/j.jpsychores.2019.04.004. Epub 2019 Apr 12.

PMID:
31003856
3.

[Telematics in ambulatory care: Exploring the nurses' perspective].

Dockweiler C, Diedrich L, Palmdorf S, Beier D, Ilic J, Kibbert M, Kirsch J, Hannemann N, Prisett F, Schmitke V, Schmidt C, Spindeler T, Sommer L, Sommer S, Stark AL, Steink├╝hler C, Stolte J, Hornberg C.

Pflege. 2019 Apr;32(2):87-96. doi: 10.1024/1012-5302/a000648. Epub 2018 Sep 28. German.

PMID:
30265200
4.

Use of a Gabapentin Protocol for the Management of Alcohol Withdrawal: A Preliminary Experience Expanding From the Consultation-Liaison Psychiatry Service.

Leung JG, Rakocevic DB, Allen ND, Handler EM, Perossa BA, Borreggine KL, Stark AL, Betcher HK, Hosker DK, Minton BA, Braus BR, Dierkhising RA, Philbrick KL.

Psychosomatics. 2018 Sep - Oct;59(5):496-505. doi: 10.1016/j.psym.2018.03.002. Epub 2018 Mar 21.

PMID:
29735241
5.

Identification of Novel Protein Expression Changes Following Cisplatin Treatment and Application to Combination Therapy.

Stark AL, Madian AG, Williams SW, Chen V, Wing C, Hause RJ Jr, To LA, Gill AL, Myers JL, Gorsic LK, Ciaccio MF, White KP, Jones RB, Dolan ME.

J Proteome Res. 2017 Nov 3;16(11):4227-4236. doi: 10.1021/acs.jproteome.7b00576. Epub 2017 Sep 29.

PMID:
28902521
6.

Community airborne particulate matter from mining for sand used as hydraulic fracturing proppant.

Peters TM, O'Shaughnessy PT, Grant R, Altmaier R, Swanton E, Falk J, Osterberg D, Parker E, Wyland NG, Sousan S, Stark AL, Thorne PS.

Sci Total Environ. 2017 Dec 31;609:1475-1482. doi: 10.1016/j.scitotenv.2017.08.006. Epub 2017 Aug 7.

7.

Genetic Variants Contributing to Colistin Cytotoxicity: Identification of TGIF1 and HOXD10 Using a Population Genomics Approach.

Eadon MT, Hause RJ, Stark AL, Cheng YH, Wheeler HE, Burgess KS, Benson EA, Cunningham PN, Bacallao RL, Dagher PC, Skaar TC, Dolan ME.

Int J Mol Sci. 2017 Mar 18;18(3). pii: E661. doi: 10.3390/ijms18030661.

8.

Milbemycin oxime (Interceptor) treatment of amphipod parasites (Hyperiidae) from several host jellyfish species.

Boonstra JL, Koneval ME, Clark JD, Schick M, Smith M, Stark AL.

J Zoo Wildl Med. 2015 Mar;46(1):158-60.

PMID:
25831592
9.

Identification and validation of genetic variants that influence transcription factor and cell signaling protein levels.

Hause RJ, Stark AL, Antao NN, Gorsic LK, Chung SH, Brown CD, Wong SS, Gill DF, Myers JL, To LA, White KP, Dolan ME, Jones RB.

Am J Hum Genet. 2014 Aug 7;95(2):194-208. doi: 10.1016/j.ajhg.2014.07.005. Epub 2014 Jul 31.

10.

Protein quantitative trait loci identify novel candidates modulating cellular response to chemotherapy.

Stark AL, Hause RJ Jr, Gorsic LK, Antao NN, Wong SS, Chung SH, Gill DF, Im HK, Myers JL, White KP, Jones RB, Dolan ME.

PLoS Genet. 2014 Apr 3;10(4):e1004192. doi: 10.1371/journal.pgen.1004192. eCollection 2014 Apr.

11.

The role of gene body cytosine modifications in MGMT expression and sensitivity to temozolomide.

Moen EL, Stark AL, Zhang W, Dolan ME, Godley LA.

Mol Cancer Ther. 2014 May;13(5):1334-44. doi: 10.1158/1535-7163.MCT-13-0924. Epub 2014 Feb 25.

12.

Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients.

Pinto N, Gamazon ER, Antao N, Myers J, Stark AL, Konkashbaev A, Im HK, Diskin SJ, London WB, Ludeman SM, Maris JM, Cox NJ, Cohn SL, Dolan ME.

Clin Pharmacol Ther. 2014 Jun;95(6):644-52. doi: 10.1038/clpt.2014.37. Epub 2014 Feb 18.

13.

EPS8 inhibition increases cisplatin sensitivity in lung cancer cells.

Gorsic LK, Stark AL, Wheeler HE, Wong SS, Im HK, Dolan ME.

PLoS One. 2013 Dec 19;8(12):e82220. doi: 10.1371/journal.pone.0082220. eCollection 2013.

14.

Genetic and epigenetic variants contributing to clofarabine cytotoxicity.

Eadon MT, Wheeler HE, Stark AL, Zhang X, Moen EL, Delaney SM, Im HK, Cunningham PN, Zhang W, Dolan ME.

Hum Mol Genet. 2013 Oct 1;22(19):4007-20. doi: 10.1093/hmg/ddt240. Epub 2013 May 29.

15.

Lymphoblastoid cell lines in pharmacogenomics: how applicable are they to clinical outcomes?

Stark AL, Dolan ME.

Pharmacogenomics. 2013 Apr;14(5):447-50. doi: 10.2217/pgs.13.32. No abstract available.

16.

Comprehensive genetic analysis of cytarabine sensitivity in a cell-based model identifies polymorphisms associated with outcome in AML patients.

Gamazon ER, Lamba JK, Pounds S, Stark AL, Wheeler HE, Cao X, Im HK, Mitra AK, Rubnitz JE, Ribeiro RC, Raimondi S, Campana D, Crews KR, Wong SS, Welsh M, Hulur I, Gorsic L, Hartford CM, Zhang W, Cox NJ, Dolan ME.

Blood. 2013 May 23;121(21):4366-76. doi: 10.1182/blood-2012-10-464149. Epub 2013 Mar 28.

17.

Identification of novel germline polymorphisms governing capecitabine sensitivity.

O'Donnell PH, Stark AL, Gamazon ER, Wheeler HE, McIlwee BE, Gorsic L, Im HK, Huang RS, Cox NJ, Dolan ME.

Cancer. 2012 Aug 15;118(16):4063-73. doi: 10.1002/cncr.26737. Epub 2012 Jan 3.

18.

Functional genetic screen of human diversity reveals that a methionine salvage enzyme regulates inflammatory cell death.

Ko DC, Gamazon ER, Shukla KP, Pfuetzner RA, Whittington D, Holden TD, Brittnacher MJ, Fong C, Radey M, Ogohara C, Stark AL, Akey JM, Dolan ME, Wurfel MM, Miller SI.

Proc Natl Acad Sci U S A. 2012 Aug 28;109(35):E2343-52. doi: 10.1073/pnas.1206701109. Epub 2012 Jul 25.

19.

Functional consequences of PRPF39 on distant genes and cisplatin sensitivity.

Stark AL, Delaney SM, Wheeler HE, Im HK, Dolan ME.

Hum Mol Genet. 2012 Oct 1;21(19):4348-55. doi: 10.1093/hmg/dds266. Epub 2012 Jul 5.

20.

Mixed effects modeling of proliferation rates in cell-based models: consequence for pharmacogenomics and cancer.

Im HK, Gamazon ER, Stark AL, Huang RS, Cox NJ, Dolan ME.

PLoS Genet. 2012 Feb;8(2):e1002525. doi: 10.1371/journal.pgen.1002525. Epub 2012 Feb 9.

21.

Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.

Wheeler HE, Gamazon ER, Stark AL, O'Donnell PH, Gorsic LK, Huang RS, Cox NJ, Dolan ME.

Pharmacogenomics J. 2013 Feb;13(1):35-43. doi: 10.1038/tpj.2011.38. Epub 2011 Aug 16.

22.

Genome-wide local ancestry approach identifies genes and variants associated with chemotherapeutic susceptibility in African Americans.

Wheeler HE, Gorsic LK, Welsh M, Stark AL, Gamazon ER, Cox NJ, Dolan ME.

PLoS One. 2011;6(7):e21920. doi: 10.1371/journal.pone.0021920. Epub 2011 Jul 6.

23.

Comprehensive evaluation of the contribution of X chromosome genes to platinum sensitivity.

Gamazon ER, Im HK, O'Donnell PH, Ziliak D, Stark AL, Cox NJ, Dolan ME, Huang RS.

Mol Cancer Ther. 2011 Mar;10(3):472-80. doi: 10.1158/1535-7163.MCT-10-0910. Epub 2011 Jan 20.

24.

Population differences in the rate of proliferation of international HapMap cell lines.

Stark AL, Zhang W, Zhou T, O'Donnell PH, Beiswanger CM, Huang RS, Cox NJ, Dolan ME.

Am J Hum Genet. 2010 Dec 10;87(6):829-33. doi: 10.1016/j.ajhg.2010.10.018. Epub 2010 Nov 25.

25.

Population differences in platinum toxicity as a means to identify novel genetic susceptibility variants.

O'Donnell PH, Gamazon E, Zhang W, Stark AL, Kistner-Griffin EO, Stephanie Huang R, Eileen Dolan M.

Pharmacogenet Genomics. 2010 May;20(5):327-37. doi: 10.1097/FPC.0b013e3283396c4e.

26.

Heritable and non-genetic factors as variables of pharmacologic phenotypes in lymphoblastoid cell lines.

Stark AL, Zhang W, Mi S, Duan S, O'Donnell PH, Huang RS, Dolan ME.

Pharmacogenomics J. 2010 Dec;10(6):505-12. doi: 10.1038/tpj.2010.3. Epub 2010 Feb 9.

27.

The psychiatric screening clinic at a VA hospital: making it work.

Sherman JM, Stark AL, Richman BW.

Hosp Community Psychiatry. 1978 Jun;29(6):393-5.

PMID:
649071
28.

UNFROZEN WATER IN APPLE SHOOTS AS RELATED TO THEIR WINTER HARDINESS.

Stark AL.

Plant Physiol. 1936 Oct;11(4):689-711. No abstract available.

29.

CORRELATION OF SPECIFIC HEAT AND PERCENTAGE OF WATER IN APPLE WOOD.

Stark AL.

Plant Physiol. 1933 Jan;8(1):168-70. No abstract available.

Supplemental Content

Loading ...
Support Center